Last updated: 2026-10-12 13:03:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Ascendis Pharma A/S (ASND) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $229.14, with a market capitalisation of $15.08B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $186.05 to $282.15. This page covers its latest market performance, valuation, price trends and company information.
$15.08B | |
$229.14 | |
$282.15 | |
$11.92 | |
$229.23 | |
7.00 | |
670.84K | |
-- | |
$282.15 | |
$186.05 | |
-- | |
-- |
Ascendis Pharma A/S (ASND) is trading at $229.14 in pre-market trading as of 2026-10-12 11:01:00, down 0.04% ($0.09) from the previous close of $229.23
Pre-market trading shows how investors are pricing ASND before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Ascendis Pharma A/S (ASND) moved from $227.31 to $229.14, representing a gain of 0.80% ($1.82).
The stock traded between $219.52 and $233.96 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 840.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 44.8%
ASND is currently trading at $229.14, placing it 44.8% of the way from its 52-week low of $186.05 to its 52-week high of $282.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
| Employees | 1189 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Ascendis Pharma A/S (ASND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.